Legal Opinion

In re Ribozyme Pharmaceuticals, Inc. Securities Litigation

District Court, D. Colorado

Decided May 1, 2000No. Nos. CIV. A. 99-B-2235, CIV. A. 99-B-2423, CIV. A. 00-B-02, CIV. A. 00-B-017PublishedCited by 25 opinions

1Opinion of the Court

MEMORANDUM OPINION AND ORDER

BABCOCK, District Judge.

This Order comes upon cross-motions for appointment of lead plaintiffs and lead counsel. Oral argument was heard on April 20, 2000. For the reasons set forth below, I grant the “Ribozyme Shareholders Group’s” motion for appointment of lead plaintiffs and lead counsel. The lead plaintiffs, therefore, are Mark Adler, Mitchell Gilbert, Barbara Brierre, and David Fasse/Jaqueline Jackson (jointly). Accordingly, I deny the motion of the “Ribozyme Lead Plaintiffs.”

I. Background

This is a class action on behalf of all persons who purchased or…

2Cases cited9 opinions

  1. Andrews v. Bechtel Power Corp.Court of Appeals for the First Circuit · 1985
  2. Adamson v. BowenCourt of Appeals for the Tenth Circuit · 1988
  3. In Re Olsten Corp. Securities Litig.District Court, E.D. New York · 1998
  4. Chill v. Green Tree Financial Corp.District Court, D. Minnesota · 1998
  5. Bayles v. American Medical Response of Colorado, Inc.District Court, D. Colorado · 1996

4 more not listed; retrieve them via the Exa API.

3Cited by25 opinions

  1. Varghese v. China Shenghuo Pharmaceutical Holdings, Inc.District Court, S.D. New York · 2008
  2. Pirelli Armstrong Tire Corp. v. LaBranche & Co.District Court, S.D. New York · 2004
  3. Foley v. Transocean Ltd.District Court, S.D. New York · 2011
  4. In Re Ribozyme Pharmaceuticals, Inc. Securities LitigationDistrict Court, D. Colorado · 2002
  5. Newby v. Enron Corp.District Court, S.D. Texas · 2002

20 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API